The people it speaks toFieldwork August 2023
74% of US adults
take dietary supplements, and 55% are regular users, in the Council for Responsible Nutrition's 2023 consumer survey of 3,192 adults.
Council for Responsible Nutrition and Ipsos, 2023DS-01 Daily Synbiotic
DS-01 Daily Synbiotic.
Backed by human trials
Limosilactobacillus reuteri SD-RD830-FR is the lead active here, studied most for vitamin B12 status. In the 215mg Digestive Health Probiotic Blend with 15 others, listed 16th. Bifidobacterium infantis SD-M63-JP is the most studied active here, with 12 human studies behind it, each one cited. Who it fits: for everyone, adults.
Full label disclosure
29Active ingredients68Human studies400 mgMAPP Microbiota-Accessible Polyphenolic Precursors
Verified by IngredientMDHow we read this product
- 01We read the label.
The panel on the left is the one we evaluated, line by line.
- 02Every active, separately.
All 29 actives checked against the clinical evidence: dose, form, and what the research actually shows.
- 03Then the formula as a whole.
Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Backed by human trials".
- 04Earned, not bought.
The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.
Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.
The receipts
68
Human studies
400 mg
MAPP Microbiota-Accessible Polyphenolic Precursors
Cross-checked against 7 documented interactions for these actives.
Read the evidenceBifidobacterium longum SD-BB536-JP, the evidence →Bifidobacterium breve SD-BR3-IT, the evidence →Lactiplanti bacillus plantarum SD-LP1-IT, the evidence →Lacticaseibacillus rhamnosus SD-LR6-IT, the evidence →Lacticaseibacillus rhamnosus HRVD113-US, the evidence →Bifidobacterium infantis SD-M63-JP, the evidence →
Inside the formula
Digestive Health Probiotic Blend
A 215mg blend of 16 ingredients, listed by weight.
Supporting roleBifidobacterium longum SD-BB536-JP
Gut barrier integrity. In the 215mg Digestive Health Probiotic Blend with 15 others, listed first.
Well studiedBifidobacterium breve SD-BR3-IT
Feeding the bacteria that make butyrate. In the 215mg Digestive Health Probiotic Blend with 15 others, listed second.
Well studiedLactiplanti bacillus plantarum SD-LP1-IT
A balanced gut microbiome. In the 215mg Digestive Health Probiotic Blend with 15 others, listed third.
Supporting roleLacticaseibacillus rhamnosus SD-LR6-IT
A balanced gut microbiome. In the 215mg Digestive Health Probiotic Blend with 15 others, listed fourth.
Well studiedLacticaseibacillus rhamnosus HRVD113-US
A balanced gut microbiome. In the 215mg Digestive Health Probiotic Blend with 15 others, listed fifth.
Well studiedBifidobacterium infantis SD-M63-JP
12 studiesA balanced gut microbiome. In the 215mg Digestive Health Probiotic Blend with 15 others, listed sixth.
Well studiedBifidobacterium lactis SD-BS5-IT
Feeding the bacteria that make butyrate. In the 215mg Digestive Health Probiotic Blend with 15 others, listed seventh.
Well studiedBifidobacterium lactis HRVD524-US
Feeding the bacteria that make butyrate. In the 215mg Digestive Health Probiotic Blend with 15 others, listed eighth.
Well studiedLactobacillus crispatus SD-LCR01-IT
A balanced gut microbiome. In the 215mg Digestive Health Probiotic Blend with 15 others, listed ninth.
Supporting roleLacticaseibacillus casei HRVD300-US
Digestive comfort. In the 215mg Digestive Health Probiotic Blend with 15 others, listed tenth.
Supporting roleBifidobacterium breve HRVD521-US
Feeding the bacteria that make butyrate. In the 215mg Digestive Health Probiotic Blend with 15 others, listed 11th.
Well studiedBifidobacterium longum HRVD90b-US
Gut barrier integrity. In the 215mg Digestive Health Probiotic Blend with 15 others, listed 12th.
Well studiedBifidobacterium lactis SD-150-BE
Feeding the bacteria that make butyrate. In the 215mg Digestive Health Probiotic Blend with 15 others, listed 13th.
Well studiedLimosilactobacillus fermentum SD-LF8-IT
A balanced gut microbiome. In the 215mg Digestive Health Probiotic Blend with 15 others, listed 14th.
Well studiedLacticaseibacillus rhamnosus SD-GG-BE
Comfort after dairy. In the 215mg Digestive Health Probiotic Blend with 15 others, listed 15th.
Well studiedLimosilactobacillus reuteri SD-RD830-FR
Vitamin B12 status. In the 215mg Digestive Health Probiotic Blend with 15 others, listed 16th.
Key driverMicronutrient Synthesis Probiotic Blend
A 38mg blend of two ingredients, listed by weight.
Supporting roleBifidobacterium adolescentis SD-BA5-IT
A balanced gut microbiome. In the 38mg Micronutrient Synthesis Probiotic Blend with one other, listed first.
Supporting roleLimosilactobacillus reuteri SD-LRE2-IT
Vitamin B12 status. In the 38mg Micronutrient Synthesis Probiotic Blend with one other, listed second.
Key driverDermatological Health Probiotic Blend
A 36mg blend of four ingredients, listed by weight.
Supporting roleLigilactobacillus salivarius SD-LS1-IT
A balanced gut microbiome. In the 36mg Dermatological Health Probiotic Blend with three others, listed first.
Supporting roleBifidobacterium lactis SD-CECT8145-SP
Feeding the bacteria that make butyrate. In the 36mg Dermatological Health Probiotic Blend with three others, listed second.
Well studiedBifidobacterium longum SD-CECT7347-SP
Gut barrier integrity. In the 36mg Dermatological Health Probiotic Blend with three others, listed third.
Well studiedLacticaseibacillus casei SD-CECT9104-SP
Digestive comfort. In the 36mg Dermatological Health Probiotic Blend with three others, listed fourth.
Supporting roleCardiovascular Health Probiotic Blend
A 13mg blend of two ingredients, listed by weight.
Supporting roleLactiplanti bacillus plantarum SD-LPLDL-UK
A balanced gut microbiome. In the 13mg Cardiovascular Health Probiotic Blend with one other, listed first.
Supporting roleBifidobacterium lactis SD-MB2409-IT
Feeding the bacteria that make butyrate. In the 13mg Cardiovascular Health Probiotic Blend with one other, listed second.
Well studiedMAPP Microbiota-Accessible Polyphenolic Precursors
A balanced gut microbiome
Supporting roleIn context
The gap this formula speaks to.
Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.
The people it speaks toFieldwork August 2023
92% of US supplement users
agree that dietary supplements are essential to maintaining their health, in the Council for Responsible Nutrition's 2023 consumer survey.
Council for Responsible Nutrition and Ipsos, 2023The people it speaks toFieldwork 2019
12.3% of US adults
met the fruit intake recommendation and 10.0% the vegetable recommendation in 2019, in the Behavioral Risk Factor Surveillance System across 49 states.
CDC, MMWR, 2022The people it speaks toFieldwork 2017 to March 2020
15% of US adults
aged 20 and over ate no breakfast on the day of their dietary recall, in the 2017 to March 2020 What We Eat in America survey.
USDA Agricultural Research Service, 2024This formulaNHANES 2017-2018, published 2021
57.6%
During 2017 to 2018, 57.6% of US adults aged 20 and over reported using a dietary supplement in the past 30 days.
CDC National Center for Health StatisticsThe people it speaks toFieldwork August 2021 to August 2023
60.2% of US adults aged 20 and over
took a dietary supplement in the past 30 days, and 38.7% took two or more, in the 2021 to 2023 National Health and Nutrition Examination Survey.
CDC National Center for Health Statistics, 202648 more
59 to 66 days
was the median time it took adults to make a new daily health habit automatic across the studies a 2024 review pooled, with individuals ranging from 4 to 335 days.
Systematic review and meta-analysis, 202461% to 74%
About 61 to 74 percent of adults refilling a long-term medicine on their own stopped within a year, versus 33 to 44 percent on one set pickup day.
Cohort study, 2015Randomised trial, 2022
Aronia berry (poly)phenol supplementation was associated with changes in arterial function measures and gut microbiome composition in the participants studied.
Clinical NutritionLe Sayec M et al., 2022 (Clinical Nutrition)PMID 36228567
Randomised trial, 2026
A single-blind randomised study reported changes in cognitive test scores and in microbiota composition with Bifidobacterium longum supplementation.
International Journal of Medical SciencesRandomised trial, 2025
Heat-sterilised L. crispatus KT-11 was associated with changes in T cell-related immune measures, which are laboratory markers of immune activity rather than clinical endpoints.
Nutrition ResearchWatanabe I et al., 2025 (Nutrition Research)PMID 39889684
Systematic review, 2025
Across the trials reviewed, polyphenol-rich interventions were associated with shifts in gut microbiota composition and in some inflammatory or oxidative stress markers.
NutrientsGonzález-Gómez Á et al., 2025 (Nutrients)PMID 40806053
Cohort study, 2026
Strain BB536 intake was associated with improvements in gastrointestinal symptom scores and odour-related metabolite measures. This is an association, not a demonstrated cause.
Journal of the International Society of Sports NutritionMeta-analysis, 2025
Pools randomised controlled trials of Lactobacillus supplementation and reports pooled effects on the outcomes those trials measured. The pooled trials span mixed species, strains and settings, so it is not strain-specific evidence for any one product or for L. reuteri in particular.
MicrobiologyOpenAzam et al., 2025 (MicrobiologyOpen)PMID 41327607
Randomised trial, 2026
A (poly)phenol-rich sugarcane extract intervention was assessed for effects on markers of gastrointestinal integrity and systemic inflammation.
Journal of the International Society of Sports NutritionRandomised trial, 2024
Reports glycaemic index, lipid panel and microbiome composition measures in adults supplemented with Lactobacillus rhamnosus. All three are laboratory markers rather than clinical outcomes.
FoodsChaiyasut C et al., 2024 (Foods)PMID 38731665
Systematic review, 2024
Across randomised trials the review examined whether probiotic supplementation changed intestinal permeability measures in adults carrying excess body weight, and reported inconsistent findings across studies and markers.
Advances in NutritionDiMattia et al., 2024 (Advances in Nutrition)PMID 38072119
Open-label trial, 2026
Bifidobacterium supplementation was reported to maintain gut microbiota stability and self-reported well-being measures across the supplementation period.
Frontiers in NutritionWang L et al., 2026 (Frontiers in Nutrition)PMID 41769651
Randomised trial, 2026
Evaluates a preparation containing Lactobacillus rhamnosus across clinical, biological and patient-reported measures in a single trial. The multidimensional design is the paper's contribution.
NutrientsMaragno P et al., 2026 (Nutrients)PMID 42123931
Systematic review, 2023
Combining earlier reviews, probiotics raised one blood antioxidant marker and lowered another marker of oxidative balance, not outcomes on their own.
Frontiers in nutritionMusazadeh et al., 2023 (Frontiers in nutrition)PMID 37637950
Randomised trial, 2025
Supplementation with Lactobacillus helveticus plus Bifidobacterium longum was reported to change hormonal and related laboratory measures relative to control. These are markers, not clinical outcomes.
Nutrition JournalShirani M et al., 2025 (Nutrition Journal)PMID 41254712
Systematic review, 2025
Oral synbiotics shifted gut microbiota composition in healthy adults, while effects on inflammatory biomarkers were inconsistent across trials.
Nutrition ReviewsCosier et al., 2025 (Nutrition Reviews)PMID 38341803
Randomised trial, 2025
A bioconversion-derived postbiotic improved measured muscle strength and shifted gut microbiota composition in healthy participants.
NutrientsJung et al., 2025 (Nutrients)PMID 41470885
Cohort study, 2026
Culture-based sampling described which intestinal lactobacilli were recoverable in young people compared with centenarians. This is an association across age groups and not a supplementation effect.
Frontiers in MicrobiologySmidt et al., 2026 (Frontiers in Microbiology)PMID 41883793
Randomised trial, 2026
A study tested a byproduct of a bacteria strain, not the live organism, so findings apply to that processed material only.
BMC MicrobiologyLiao H et al., 2026 (BMC Microbiology)PMID 41566207
Randomised trial, 2026
The CRANMOOD randomised controlled trial assessed effects of (poly)phenol-rich cranberry on mental health measures in students.
Clinical NutritionKamarunzaman NNZ et al., 2026 (Clinical Nutrition)PMID 42134099
Meta-analysis, 2025
Pooled analysis of chokeberry supplementation examined cardiometabolic outcome measures across the available trials.
NutrientsFrumuzachi O et al., 2025 (Nutrients)PMID 40362797
Meta-analysis, 2025
A meta-analysis of Moringa oleifera supplementation on cardiometabolic outcomes, in which phenolic content is discussed as a constituent.
NutrientsCrișan D et al., 2025 (Nutrients)PMID 41305552
Randomised trial, 2026
Oral L. crispatus M247 combined with vaginal laser therapy was assessed for clinical measures and vaginal microbiota composition. Microbiota shifts are community markers rather than clinical outcomes on their own.
Lasers in Medical ScienceDi Pierro F et al., 2026 (Lasers in Medical Science)PMID 42234022
Meta-analysis, 2026
Pooled trials reported modestly lower circulating cortisol with probiotic supplementation, with the certainty of the pooled estimate graded as limited.
BMC nutritionGandomkar et al., 2026 (BMC nutrition)PMID 42032711
Randomised trial, 2026
A synbiotic combining strains including this species with fibre was compared against control for abdominal visceral fat measures and gut microbiota in adults carrying excess body weight. The intervention was a multi-component synbiotic, so nothing is attributable to one strain.
Clinical NutritionLi et al., 2026 (Clinical Nutrition)PMID 41512635
Randomised trial, 2026
A 12-week double-blind placebo-controlled exploratory pilot of a heat-treated Bifidobacterium preparation reported pilot-scale findings the authors describe as exploratory and needing confirmation.
BMC NutritionChai H et al., 2026 (BMC Nutrition)PMID 42436590
Randomised trial, 2022
A low glycaemic index energy-restricted diet changed faecal short-chain fatty acid concentrations, while adding Lactobacillus rhamnosus did not produce a detectable additional change. A failure to detect a difference, not evidence that none exists.
European Review for Medical and Pharmacological SciencesRandomised trial, 2026
Infants given a specific probiotic strain had fewer caregiver-reported bouts of skin irritation and breathing or digestive symptoms than infants without it, specific to that strain and dose.
QJMYuan et al., 2026 (QJM)PMID 42308545
Randomised trial, 2026
A randomised trial of the M-63 strain reported gut environment measures and bowel function during weaning.
Pediatric ResearchArai S et al., 2026 (Pediatric Research)PMID 42056537
Randomised trial, 2014
Preterm neonates given Bifidobacterium breve M-16V had higher faecal bifidobacteria counts than those given placebo.
PloS onePatole et al., 2014 (PloS one)PMID 24594833
Randomised trial, 2016
In growth restricted very preterm infants, M-16V supplementation raised faecal bifidobacteria counts compared with placebo.
The journal of maternal-fetal & neonatal mediRandomised trial, 2026
In early childhood, a different specific probiotic strain was linked to fewer reported bouts of skin irritation and breathing symptoms than no supplement, specific to that strain.
Frontiers in NutritionChen et al., 2026 (Frontiers in Nutrition)PMID 42293186
Randomised trial, 2025
A clinical trial of the YLGB-1496 strain reported changes in gut microbiota composition and immune measures against comparator.
Frontiers in NutritionRandomised trial, 2026
A randomised controlled trial reported that Bifidobacterium longum subsp. infantis B8762 altered infant gut microbial and metabolic profiles.
Microbial pathogenesisMa et al., 2026 (Microbial pathogenesis)PMID 41802657
Randomised trial, 2026
Bifidobacterium animalis subsp. lactis XLTG11 given with a Lactobacillus plantarum strain shifted gut microbiota composition relative to control. Community composition is a measured microbial readout and not a health endpoint.
European Journal of NutritionChen et al., 2026 (European Journal of Nutrition)PMID 42090020
Randomised trial, 2026
The authors examined whether the M-63 strain shifts gut microbial composition across the weaning transition.
Pediatric ResearchBettocchi S et al., 2026 (Pediatric Research)PMID 42343102
Randomised trial, 2025
A trial compared a live versus a heat-inactivated Bifidobacterium preparation in preterm infants head-to-head, to test whether the bacteria needed to be alive for any effect.
Archives of disease in childhood, Fetal and neonatal editionCohort study, 2016
In a before-and-after cohort of preterm newborns, routine Bifidobacterium breve M-16V use was linked to better outcomes than the period before it started, an association rather than a proven cause.
PloS onePatole SK et al., 2016 (PloS one)PMID 26953798
Randomised trial, 2026
A 12-month randomised trial measuring progression of early enamel lesions in children given a probiotic supplement.
European Journal of Oral SciencesRandomised trial, 2026
A randomised trial of early postoperative synbiotic supplementation, with Lactobacillus rhamnosus among the strains, reporting gastrointestinal tolerance measures after bariatric surgery.
Clinical NutritionAltunsaray A et al., 2026 (Clinical Nutrition)PMID 42400993
Systematic review, 2026
A review of probiotics in hospitalised infants after cardiac surgery reported intestinal mucosal integrity markers and microbial composition. Markers, not clinical outcomes.
Frontiers in ImmunologyZhang Z et al., 2026 (Frontiers in Immunology)PMID 42112337
Systematic review, 2026
The review concluded that early-life probiotic effects on respiratory infection measures are strain-specific and cannot be generalised across products.
NutrientsCarnazzo SM et al., 2026 (Nutrients)PMID 42451071
Randomised trial, 2026
School-age follow-up of a single-strain versus triple-strain probiotic trial reported neurodevelopmental and atopy measures years after the original supplementation period.
NutrientsAthalye-Jape G et al., 2026 (Nutrients)PMID 41515257
Meta-analysis, 2023
Pooled trials of a probiotic strain in infants reported measurable effects on the outcomes tracked, along with acceptable tolerability.
FoodsGuo H et al., 2023 (Foods)PMID 38137255
Randomised trial, 2026
In a trial against placebo, the dose and timing of Bifidobacterium infantis both changed how well the strain took hold in infants' guts.
mSphereO'Brien et al., 2026 (mSphere)PMID 41427732
Systematic review, 2025
Pooled data support vertical mother-to-infant transmission of Bifidobacterium strains in early life, with transmission proportions varying by species and delivery mode.
NPJ Biofilms and MicrobiomesRandomised trial, 2026
Reports executive function test scores in children given a probiotic supplement. Cognitive test scores are measures of performance on the task, and the report should be read at that level.
Neuropsychopharmacology ReportsMeta-analysis, 2026
Systematic review and meta-analysis of trials of the DSM 17938 strain in preterm newborns and in infants with excessive crying, pooling the crying and tolerance outcomes those trials reported.
NutritionBianchi et al., 2026 (Nutrition)PMID 42485904
Population figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Every one of these is a fact the engine could ground.
Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.
- Studied in people12 human studies on Bifidobacterium infantis SD-M63-JP back this formula, each one cited.
- A mechanism that is settledHow Bifidobacterium longum SD-BB536-JP and Bifidobacterium breve SD-BR3-IT work is settled pharmacology.
- Studied together, not just separatelyBifidobacterium longum SD-BB536-JP and Bifidobacterium lactis SD-BS5-IT have been studied together, not only separately.
- Recent work on the recordThe most recent study on this record was published in 2023.
- Why this formatIt is a capsule, so the amount per serving is fixed and travels without measuring.
- The exact form, describedThe label names its forms exactly: Bifidobacterium longum, lyophilised, Bifidobacterium breve M-16V, lyophilised, CFU declared, Named strain material. The record says what each one is and what it suits.
- A declared blend totalDigestive Health Probiotic Blend declares its total, 215 mg per serving, with 16 ingredients listed by weight.
- Where it comes from and how it is madeBifidobacterium longum SD-BB536-JP is made by fermentation.
- Positions this formula already qualifies forThis formula already qualifies for positions beyond the one it is sold into, on the evidence it carries.
- A position nobody is holding yetSome of those positions are ones almost nobody is selling to yet.
What the trials show
What the trials show about timing.
Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.
- EarlyBifidobacterium lactis SD-BS5-ITabout 8 weeks of daily useBuilds with daily use
In a randomised preliminary trial, sixteen healthy national-level cross-country skiers took Bifidobacterium lactis BL-99 daily for 8 weeks. Over the supplementation period, gut abundance of Bifidobacterium animalis rose about forty-fold and blood triglyceride levels shifted.
Li et al., 2023 (Nutrients)PMID 37960207
Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.
How each ingredient usually behaves over time.
12 ingredients, from each one's own page.
- Bifidobacterium longum SD-BB536-JPAbout four weeks
Digestive changes usually show up somewhere between one and four weeks of daily use. Trials that looked at stress and mood measures read them at four weeks or later.
- Bifidobacterium breve SD-BR3-IT
Nobody has published a reliable time to effect for this strain in adults. The infant studies dosed daily for weeks, so weeks is the honest expectation rather than days.
- Lactiplanti bacillus plantarum SD-LP1-ITAbout one to three weeks
Digestive changes with spore probiotics generally show up over one to three weeks of daily use. Since the species is transient, effects track continued intake.
- Lacticaseibacillus rhamnosus SD-LR6-ITAbout one to two weeks
Most people notice digestive changes over one to two weeks. Immune related measures in trials are read after eight to twelve weeks of continuous use.
- Bifidobacterium infantis SD-M63-JPFour weeks
Is the length most trials ran. Some people report calmer digestion inside the first two weeks, and the fuller picture tends to land around week four.
- Bifidobacterium lactis SD-BS5-ITAbout one to four weeks
Give it one to four weeks of daily use. Stool regularity and less day-to-day bloating are usually the first things people notice.
6 more
- Lactobacillus crispatus SD-LCR01-IT
Community shifts are read by swab or sequencing over weeks rather than felt. Nobody has established a reliable sensation timeline for this one.
- Lacticaseibacillus casei HRVD300-USAbout one to two weeks
Digestive changes usually turn up in the first one to two weeks. The steadier pattern in bowel habit tends to settle around week three or four.
- Limosilactobacillus fermentum SD-LF8-ITWeeks, not days
What ME-3 was studied for is redox and lipid readings on a blood panel, so a repeat test tells you more than how your day feels.
- Lacticaseibacillus rhamnosus SD-GG-BEAbout two to four weeks
Give it two to four weeks of daily intake. The strains show up in stool within days, but the digestive changes people report land in that two to four week window.
- Limosilactobacillus reuteri SD-RD830-FRWithin one to two weeks
Digestive changes tend to land within one to two weeks of daily use. Gum and mouth measures in lozenge studies read out over two to four weeks.
- Bifidobacterium adolescentis SD-BA5-ITTwo to four weeks
Changes show up in stool pattern and comfort rather than as a sensation.
How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.
Capsule
It is a capsule, so the amount per serving is fixed and travels without measuring.
Best forMost standard doses, and anywhere a short, clean label is the point.
Questions shoppers ask
- Is DS-01 Daily Synbiotic independently verified?
- Yes. IngredientMD reviewed this formula independently and verified it in Oct 2026. The verdict is earned, not bought: brands can't edit or purchase it.
- What's in DS-01 Daily Synbiotic?
- DS-01 Daily Synbiotic is built on Digestive Health Probiotic Blend, Bifidobacterium longum SD-BB536-JP, Bifidobacterium breve SD-BR3-IT, Lactiplanti bacillus plantarum SD-LP1-IT, Lacticaseibacillus rhamnosus SD-LR6-IT, Lacticaseibacillus rhamnosus HRVD113-US, and more. Each ingredient links to its own evidence page on IngredientMD.
- Were ingredient interactions checked?
- Yes. The combination was screened against 7 documented interactions for these actives in IngredientMD's interaction database.
- Who is IngredientMD?
- IngredientMD is an independent supplement-science platform. We analyze ingredients and formulas against clinical research, and we verify products only when they clear our bar. Labs run the tests. We review the results.
Sell a formula this good?
Put an earned verification on your own product page.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.
Independent review by IngredientMD, not commissioned by SeedWork at Seed? This verification is yours to claim →